Michael Greenhalgh is COO at Tabula Rasa HealthCare, Inc. (TRHC). They have made 14 open-market trades across 1 company since 2020, most recently 2023-11-03.
CIK 0001805817
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $11K since 2022, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TRHC | 221,875 | $2.3M |
Shares reported on the most recent Form 4, priced at the 2023-11-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRHC | BUY | 2022-03-01 | 2022-03-04 | $5.63 | $11K | -29.5% | -7.6% | -51.4% |
| TRHC | SELL | 2022-01-14 | 2022-01-18 | $14.87 | $30K | -25.2% | -53.2% | -69.7% |
| TRHC | SELL | 2022-01-12 | 2022-01-14 | $15.69 | $17K | -29.2% | -45.9% | -70.3% |
| TRHC | SELL | 2022-01-03 | 2022-01-05 | $15.59 | $42K | -3.6% | -38.7% | -62.0% |
| TRHC | SELL | 2021-08-05 | 2021-08-09 | $38.08 | $179K | -10.5% | -19.8% | -62.6% |
| TRHC | SELL | 2021-06-17 | 2021-06-22 | $49.36 | $346K | -8.3% | -16.6% | -42.8% |
| TRHC | SELL | 2021-06-02 | 2021-06-04 | $46.00 | $46K | +11.0% | +12.4% | -25.6% |
| TRHC | SELL | 2021-01-27 | 2021-01-29 | $60.00 | $960K | -1.9% | -31.1% | -17.8% |
| TRHC | SELL | 2021-01-21 | 2021-01-22 | $52.20 | $157K | +4.9% | -7.8% | -15.0% |
| TRHC | SELL | 2021-01-12 | 2021-01-14 | $46.35 | $45K | +20.0% | -2.2% | -15.9% |
| TRHC | SELL | 2021-01-04 | 2021-01-06 | $41.77 | $107K | +12.6% | +15.0% | -5.8% |
| TRHC | SELL | 2020-06-17 | 2020-06-19 | $59.25 | $59K | -6.1% | +1.2% | -27.3% |
| TRHC | SELL | 2020-05-27 | 2020-05-29 | $60.00 | $120K | +4.5% | +0.4% | -6.9% |
| TRHC | SELL | 2020-04-27 | 2020-04-29 | $62.55 | $125K | -9.3% | -16.8% | -13.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.